[AUPH] Aurinia Pharmaceuticals Inc


Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization: 99.78 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 2.18 Change: 0.03 (1.4%)
Ext. hours: 2.19 Change: 0.01 (0.46%)

chart AUPH

Refresh chart

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding32.29 M EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters Sales Growth - Q/Q P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA ROE ROI
Current Ratio Quick Ratio Long Term Debt/Equity Debt Ratio
Gross Margin Operating Margin Net Profit Margin Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities Cash From Investing Activities Cash From Operating Activities Gross Profit
Net Profit Operating Profit Total Assets Total Current Assets
Total Current Liabilities Total Debt Total Liabilities Total Revenue
Technical Data
High 52 week7.64 Low 52 week4.53 Last close7.2 Last change16.32%
RSI57.14 Average true range0.31 Beta0.79 Volume1.13 M
Simple moving average 20 days11.65% Simple moving average 50 days10.47% Simple moving average 200 days23.03%
Performance Data
Performance Week8.93% Performance Month13.92% Performance Quart35.85% Performance Half27.43%
Performance Year44.58% Performance Year-to-date5.57% Volatility daily4.33% Volatility weekly9.69%
Volatility monthly19.86% Volatility yearly68.8% Relative Volume859.31% Average Volume1.02 M
New High New Low


2020-05-26 08:16:17 | Aurinia Submits FDA New Drug Admission For Novel Voclosporin Kidney Treatment

2020-05-26 06:05:00 | Aurinia Completes Submission of New Drug Application to the U.S. Food & Drug Administration for Voclosporin for the Treatment of Lupus Nephritis

2020-05-20 10:04:41 | Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks

2020-05-19 16:26:00 | Aurinia Pharmaceuticals Inc AUPH Q1 2020 Earnings Call Transcript

2020-05-19 06:10:40 | Aurinia Pharmaceuticals Inc. TSE:AUP Released Earnings Last Week And Analysts Lifted Their Price Target To US$32.00

2020-05-15 16:05:00 | Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference

2020-05-14 17:35:09 | Aurinia Pharmaceuticals AUPH Reports Q1 Loss, Misses Revenue Estimates

2020-05-14 16:02:00 | Aurinia Reports First Quarter 2020 Financial Results and Recent Operational Highlights

2020-05-07 06:05:00 | Aurinia Pharmaceuticals to Release First Quarter 2020 Financial Results on May 14, 2020

2020-05-05 12:30:04 | Analysts Estimate Aurinia Pharmaceuticals AUPH to Report a Decline in Earnings: What to Look Out for

2020-04-29 13:12:12 | Ken Fisher's Top 5 1st-Quarter Buys

2020-04-27 06:05:00 | Aurinia Appoints Joe Miller as Chief Financial Officer

2020-04-21 07:33:49 | One Thing To Remember About The Aurinia Pharmaceuticals Inc. TSE:AUP Share Price

2020-04-20 06:05:00 | Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors

2020-04-08 19:32:02 | Hedge Funds Have Never Been This Bullish On Aurinia Pharmaceuticals Inc AUPH

2020-03-18 06:05:00 | Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundation 2020 Spring Clinical Meetings

2020-03-17 06:00:00 | Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland

2020-03-16 06:05:00 | Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis

2020-03-12 07:00:00 | Aurinia Launches Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative

2020-03-05 16:02:00 | Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights

2020-03-05 14:30:00 | Aurinia Pharmaceuticals, Inc. to Host Earnings Call

2020-03-04 08:36:01 | Do Options Traders Know Something About Aurinia AUPH Stock We Don't?

2020-03-03 06:30:00 | Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020

2020-02-25 06:30:00 | Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team

2020-02-21 16:05:00 | Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference

2020-02-04 10:20:46 | 3 “Strong Buy” Small-Cap Stocks with Towering Growth Prospects

2020-01-23 09:11:02 | Options Traders Expect Huge Moves in Aurinia Pharmaceuticals AUPH Stock

2020-01-21 05:01:02 | Do Directors Own Aurinia Pharmaceuticals Inc. TSE:AUP Shares?

2020-01-02 07:00:00 | My Top Stock Pick for 2020 Is a Super Strong Finisher From 2019

2019-12-13 10:29:14 | Hedge Funds Have Never Been More Bullish On Aurinia Pharmaceuticals Inc AUPH

2019-12-12 09:26:00 | Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares

2019-12-10 16:16:09 | Why Biotech ETFs are Surging to New Highs

2019-12-09 21:00:00 | Aurinia Prices US$166.7 Million Public Offering of Common Shares

2019-12-09 06:01:00 | Aurinia Announces Public Offering of Common Shares

2019-12-07 08:35:07 | The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling

2019-12-06 07:39:38 | The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend

2019-12-06 05:00:00 | A 60% Tumble for Sage Therapeutics, and Two More Numbers to Know

2019-12-05 10:08:00 | Biotech Stocks Are Making Wild Moves Amid a Deluge of Trial Data

2019-12-05 08:51:01 | Aurinia's Lupus Candidate Succeeds in Pivotal Study, Stock Up

2019-12-05 07:14:16 | The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission

2019-12-04 16:59:00 | Aurinia Pharmaceuticals surges more than 110%, after positive trial for lupus-related drug

2019-12-04 16:05:00 | Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis

2019-12-03 06:30:00 | Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference

2019-12-02 08:38:01 | Aurinia Pharmaceuticals AUPH Catches Eye: Stock Jumps 9.8%

2019-12-02 05:07:35 | Aurinia Pharmaceuticals Inc.'s TSE:AUP Shift From Loss To Profit

2019-11-14 17:15:10 | Aurinia Pharmaceuticals AUPH Reports Q3 Loss, Tops Revenue Estimates

2019-11-14 16:02:00 | Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

2019-11-13 16:05:00 | Aurinia Announces Updates to the Board of Directors

2019-11-09 15:55:46 | Were Hedge Funds Right About Souring On Aurinia Pharmaceuticals Inc AUPH?

2019-11-07 10:30:03 | Aurinia Pharmaceuticals AUPH May Report Negative Earnings: Know the Trend Ahead of Next Week's Release